Literature DB >> 13922208

Studies on the in vitro antitumor activity of fatty acids. IV. The esters of acids closely related to 10-hydroxy-2-decenoic acids from royal jelly against transplantable mouse leukemia.

G F TOWNSEND, W H BROWN, E E FELAUER, B HAZLETT.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/pharmacology; BEES/chemistry; FATTY ACIDS/pharmacology; LEUKEMIA/experimental

Mesh：

Substances：

Year:  1961        PMID： 13922208     DOI： 10.1139/o61-195

Source DB:  PubMed          Journal:  Can J Biochem Physiol


× No keyword cloud information.
  9 in total

1.  Connective tissue growth factor, a regulator related with 10-hydroxy-2-decenoic acid down-regulate MMPs in rheumatoid arthritis.

Authors:  Jian-guang Wang; Jian Ruan; Chun-yang Li; Jian-min Wang; Yan Li; Wei-tao Zhai; Wei Zhang; Hui Ye; Nian-han Shen; Kang-fu Lei; Xiu-fang Chen; Xin-yu Yang
Journal:  Rheumatol Int       Date:  2011-08-18       Impact factor: 2.631

2.  Antidepressant-like activity of 10-hydroxy-trans-2-decenoic Acid, a unique unsaturated Fatty Acid of royal jelly, in stress-inducible depression-like mouse model.

Authors:  Satoru Ito; Yuji Nitta; Hidefumi Fukumitsu; Hitomi Soumiya; Kumiko Ikeno; Tadashi Nakamura; Shoei Furukawa
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-24       Impact factor: 2.629

3.  The functional property of royal jelly 10-hydroxy-2-decenoic acid as a melanogenesis inhibitor.

Authors:  Chi-Chung Peng; Hui-Tzu Sun; I-Ping Lin; Ping-Chung Kuo; Jen-Chieh Li
Journal:  BMC Complement Altern Med       Date:  2017-08-09       Impact factor: 3.659

4.  10-hydroxy-2-decenoic acid of royal jelly exhibits bactericide and anti-inflammatory activity in human colon cancer cells.

Authors:  Yuan-Chang Yang; Wing-Ming Chou; Debora Arny Widowati; I-Ping Lin; Chi-Chung Peng
Journal:  BMC Complement Altern Med       Date:  2018-07-03       Impact factor: 3.659

5.  Metabolism and pharmacokinetics of medium chain fatty acids after oral administration of royal jelly to healthy subjects.

Authors:  Masayuki Yamaga; Hiroko Tani; Ayanori Yamaki; Tomoki Tatefuji; Ken Hashimoto
Journal:  RSC Adv       Date:  2019-05-17       Impact factor: 4.036

6.  10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells.

Authors:  Hiroshi Izuta; Yuichi Chikaraishi; Masamitsu Shimazawa; Satoshi Mishima; Hideaki Hara
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-22       Impact factor: 2.629

7.  Hydroxy decenoic acid down regulates gtfB and gtfC expression and prevents Streptococcus mutans adherence to the cell surfaces.

Authors:  Behnam Yousefi; Shahrooz Ghaderi; Alireza Rezapoor-Lactooyi; Niusha Amiri; Javad Verdi; Alireza Shoae-Hassani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-07-28       Impact factor: 3.944

8.  INHIBITION OF AN EHRLICH ASCITES TUMOR IN VIVO BY PARTIALLY NEUTRALIZED SOLUTIONS OF SODIUM LACTATE.

Authors:  C D STEVENS; R ATCHLEY; W HERZOG; C J FELDHAKE; M E TURNER
Journal:  Br J Cancer       Date:  1963-06       Impact factor: 7.640

9.  Daily Oral Administration of Protease-Treated Royal Jelly Protects Against Denervation-Induced Skeletal Muscle Atrophy.

Authors:  Tomohiko Shirakawa; Aki Miyawaki; Takuma Matsubara; Nobuaki Okumura; Hideto Okamoto; Naoya Nakai; Thira Rojasawasthien; Kazumasa Morikawa; Asako Inoue; Akino Goto; Ayako Washio; Toshiyuki Tsujisawa; Tatsuo Kawamoto; Shoichiro Kokabu
Journal:  Nutrients       Date:  2020-10-11       Impact factor: 5.717
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.